Developing a SARS-CoV-2 Vaccine at Warp Speed

This Viewpoint discusses the mechanisms of the 5 leading COVID-19 vaccine candidates-2 messenger RNA vaccines, 1 recombinant VSV vector product, and 2 replication-defective adenovirus vector approaches-and emphasizes the need to demonstrate safety as well as efficacy to facilitate broad uptake by the public.